← FDA Drug Approvals (Drugs@FDA)

BROMPHENIRAMINE MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1976-05-20

Drug application

FDA Application #
ANDA083821
Application type
Abbreviated New Drug Application (Generic)
Brand name
BROMPHENIRAMINE MALEATE
Generic name
Brompheniramine Maleate
Active ingredients
BROMPHENIRAMINE MALEATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
WATSON LABS
First approval
1976-05-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown